We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mummified Liver Samples Allow Mapping of Antique Hepatitis Virus Genes

By LabMedica International staff writers
Posted on 06 Jun 2012
Advanced modern gene mapping techniques applied to liver samples taken from a 500 hundred year-old mummy have generated what may be the complete sequence of the oldest hepatitis B virus (HBV) isolate and the most ancient full viral genome known so far. More...


Investigators at the Hebrew University of Jerusalem (Israel) and their South Korean colleagues conducted DNA sequence mapping of liver biopsy specimens recovered from a mummified Korean child from the 16th century CE.

Analysis of the complete HBV genome (3,215 base pairs) was published in the May 21, 2012, online edition of the journal Hepatology. Results revealed a unique HBV genotype C2 sequence commonly spread in Southeast Asia, which probably represents an HBV strain that infected the population of Korea about five hundred years ago.

The calculated time of a most recent common ancestor suggests that the Korean HBV sequence origin dates back at least 3,000 years and possibly as long as 100,000 years. This isolate most likely represents the earliest human HBV sequence that colonized Southeast Asia via human migration.

The results of this study may help trace the spread of HBV. According to the World Health Organization, there are over 400 million carriers of the virus worldwide, predominantly in Africa, China, and South Korea, where up to 15% of the population are carriers of the virus. Fortunately, universal immunization of newborns against HBV in Israel and in South Korea has lead to a massive decline in the incidence of infection.

Related Links:

Hebrew University of Jerusalem




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Online QC Software
Acusera 24•7
Automated Urinalysis Solution
UN-9000
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.